FOLD

Companies
NASDAQ
Amicus Therapeutics Inc.
Health Care
Price Chart
Overview

About FOLD

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Market Cap
$3.0B
Volume
21.1M
Avg. Volume
16.1M
P/E Ratio
45.125
Dividend Yield
0.00%
Employees
701.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.97
Moderate Correlation
Volatility
Medium (0.37)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for FOLD.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, FOLD shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$3.0B
Volume21.1M
P/E Ratio45.13
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 19, 2025

PortfolioPilot Analysis

Get AI-powered insights on how FOLD fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025